Dr. Bhatt’s comment on the “DAPA-TAVI” dance was absolutely hilarious 😂🕺 nejm.org/doi/full/10.10… DapaTAVI x.com/NEJM/status/19… #ACC25 #25JCS

🚨The FRESH-UP trial is out! Fluid restriction in HF ⛔💧 Cited in our guidelines 📘 🔼 thirst, 🔽QoL, but no change in outcomes. Raises questions about routine restriction. #25JCS #ACC25 💔 Nature Med nature.com/articles/s4159… Discussion movie youtu.be/aglwa9kF0Gs?si…

📢 New paper is now open access Proud to be part of this work led by Prof Gillian E Mead 💡 We highlight the importance of multiple long-term conditions (MLTCs) in systematic reviews, and propose the term “co-long-term conditions” 💬 🔗onlinelibrary.wiley.com/doi/10.1002/ce…

When exactly does a patient transition from ACS to chronic coronary syndrome (CCS)? The timeline isn’t always clear—but it matters.

*New* 2025 JCS/JHFS Japanese Guidelines Prevention of #HF #SGLT2i class I (4 T2D & 4 CKD RCTs) #nsMRA class I (FIDELIO FIGARO) Treatment of #HFpEF #SGLT2i class I (DELIVER EMPEROR SOLOIST) #nsMRA class IIa (FINEARTS) #sMRA class IIb (TOPCAT) #ARNI/#ARB class IIb (PARAGON/CHARM)

Final day of the APSC 2025 Busan Busan 2025 !!! If you see any of these faces, don't be shy... say HI ! #CardioX #CardioTwitter #APSCBusan2025 #APSC2025 Asian Pacific Society of Cardiology Jonathan Sung Donna Shu-Han Lin, MD Purich Surunchupakor Faisal Habib

🎮 Introducing the FOOTSTEPS Trial Protocol, a #RCT testing gamification to increase physical activity in #CVD patients. Will #LossFraming or #GainFraming, with/without social support, drive better outcomes? Primary endpoint: step count change 📊. Read all about it here ⬇️